Hope Rugo

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés, David W. Cescon, Hope S. Rugo et al. · The Lancet · 2020 · 1.8K citations · Full text

Medicine, Oncology, Pharmacology +16

MRI Phenotype Is Associated With Response to Doxorubicin and Cyclophosphamide Neoadjuvant Chemotherapy in Stage III Breast Cancer

Laura Esserman, Elizabeth Kaplan, S. C. Partridge et al. · Annals of Surgical Oncology · 2001 · 169 citations

Medicine, Oncology, Radiology +16

The Modified Total Neuropathy Score: A Clinically Feasible and Valid Measure of Taxane-Induced Peripheral Neuropathy in Women With Breast Cancer

Meredith A. Wampler, Christine Miaskowski, Nancy N. Byl et al. · 2006 · 67 citations

Medicine, Neurology, Oncology +13

Abstract PO4-19-05: OptimICE-pCR: De-escalation of therapy in early-stage TNBC patients who achieve pCR after neoadjuvant chemotherapy with checkpoint inhibitor therapy (Alliance A012103)

Sara M. Tolaney, Karla V. Ballman, Charles M. Perou et al. · Cancer Research · 2024 · 12 citations

Medicine, Oncology, Pharmacology +17